All In MedTech

Company

Agilent Technologies

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

A

NYSE · AGILENT TECHNOLOGIES, INC.

Public float

Unknown

Not reported in US filings

Revenue

$6.95B

Fiscal year ending Oct 31, 2025

Net income

$1.30B

Fiscal year ending Oct 31, 2025

R&D spending

$455M

Fiscal year ending Oct 31, 2025

Cash

$1.76B

As of Jul 31, 2026

Long-term debt

$3.65B

As of Jul 31, 2026

Shares outstanding

281.9M

As of Aug 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$4.0M–
2024––$1.20B–
2022––$600M–
2021––$848M–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Agilent Technologies we have 3 shareholders with 5% or more and 1 government grant totalling $13K.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 18 since 2015.

Search the Clearance Tracker

15 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

No device trials list this company as lead sponsor.

Reports received

8

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

7

88% of reports

Injury reports

1

13% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2311000
Jan 249000
Feb 245000
Mar 246000
Apr 2411000
May 247000
Jun 247000
Jul 245000
Aug 245000
Sep 249100
Oct 244000
Nov 249000
Dec 2412000
Jan 255000
Feb 2511000
Mar 255000
Apr 2511000
May 258000
Jun 251000
Jul 251000
Aug 252000
Sep 251000
Oct 253000
Nov 252000
Dec 251000
Jan 260000
Feb 260000
Mar 260000
Apr 261000
May 260100
Jun 260000
Jul 262000
Aug 260000
Sep 261000
Oct 260000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

3 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

6 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.